AB InBev CEO: Beer Unaffected by Weight-Loss Drug Trends

Reported 8 days ago

Anheuser-Busch InBev CEO Michel Doukeris expressed confidence that beer is not significantly impacted by the rising popularity of weight-loss drugs like Wegovy. He indicated that beer's lower calorie and carb options make it a suitable choice for consumers focused on maintaining a balanced diet, distinguishing it from sweeter beverage categories like wine and cocktails.

Source: YAHOO

View details

You may also interested in these wikis

Back to all Wikis